Hydrochlorothiazide, which for decades has been a standard treatment to prevent the recurrence of calcium-containing kidney stones, did not lower the rate of stone recurrence in the NOSTONE randomized ...
Please provide your email address to receive an email when new articles are posted on . SGLT2 inhibitors and hydrochlorothiazide both reduced muscle sympathetic nerve activity. Empagliflozin also ...
Please provide your email address to receive an email when new articles are posted on . Longer use of hydrochlorothiazide was linked to an increased risk for keratinocyte carcinoma and melanoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback